http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 08:00:46 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html <p>RedHill Biopharma Ltd. (Nasdaq: RDHL) has entered into a definitive agreement for a private placement of 8,571,429 American Depositary Shares at $0.70 per ADS, with expected gross proceeds of approximately $6 million before fees and expenses.</p> <p>The offering also includes two series of warrants, each to purchase up to 8,571,429 ADSs. Series A-1 warrants carry an exercise price of $0.86 per ADS, are immediately exercisable, and expire five years after the registration effectiveness date. Series A-2 warrants have an exercise price of $0.70 per ADS, are immediately exercisable, and expire 18 months after the effectiveness date. If both warrant series are http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html Thu, 18 Jun 2026 08:00:46 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html <p>RedHill Biopharma Ltd. (Nasdaq: RDHL) has entered into a definitive agreement for a private placement of 8,571,429 American Depositary Shares at $0.70 per ADS, with expected gross proceeds of approximately $6 million before fees and expenses.</p> <p>The offering also includes two series of warrants, each to purchase up to 8,571,429 ADSs. Series A-1 warrants carry an exercise price of $0.86 per ADS, are immediately exercisable, and expire five years after the registration effectiveness date. Series A-2 warrants have an exercise price of $0.70 per ADS, are immediately exercisable, and expire 18 months after the effectiveness date. If both warrant series are http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html Thu, 18 Jun 2026 08:00:46 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html <p>RedHill Biopharma Ltd. (Nasdaq: RDHL) has entered into a definitive agreement for a private placement of 8,571,429 American Depositary Shares at $0.70 per ADS, with expected gross proceeds of approximately $6 million before fees and expenses.</p> <p>The offering also includes two series of warrants, each to purchase up to 8,571,429 ADSs. Series A-1 warrants carry an exercise price of $0.86 per ADS, are immediately exercisable, and expire five years after the registration effectiveness date. Series A-2 warrants have an exercise price of $0.70 per ADS, are immediately exercisable, and expire 18 months after the effectiveness date. If both warrant series are http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html Thu, 18 Jun 2026 08:00:46 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html <p>RedHill Biopharma Ltd. (Nasdaq: RDHL) has entered into a definitive agreement for a private placement of 8,571,429 American Depositary Shares at $0.70 per ADS, with expected gross proceeds of approximately $6 million before fees and expenses.</p> <p>The offering also includes two series of warrants, each to purchase up to 8,571,429 ADSs. Series A-1 warrants carry an exercise price of $0.86 per ADS, are immediately exercisable, and expire five years after the registration effectiveness date. Series A-2 warrants have an exercise price of $0.70 per ADS, are immediately exercisable, and expire 18 months after the effectiveness date. If both warrant series are http://www.streetinsider.com/Equity+Offerings/RedHill+Biopharma+sets+%246M+private+placement+with+warrant+upside/26663090.html Thu, 18 Jun 2026 08:00:46 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/Press+Releases/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html <div class="xn-content"> <p class="prntac"><i><money>$6 million</money> upfront with up to approximately <money>$13.4 million</money> of potential aggregate gross proceeds upon the exercise in full of warrants</i></p><p><span class="legendSpanClass"><location value="LU/il..telavv" idsrc="xmltag.org" >TEL AVIV, Israel</location> &amp; <location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH, N.C.</location></span>, <span class="legendSpanClass"><chron>June 18, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 8,571,429 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each ADS representing ten thousand (10,000) ordinary shares of the http://www.streetinsider.com/PRNewswire/RedHill+Biopharma+Announces+Up+To+%2419.4+Million+Private+Placement/26663073.html Thu, 18 Jun 2026 08:00:00 -0400 CPIX O.00044279 O.13804664 RDHL http://www.streetinsider.com/Corporate+News/RedHill+initiates+enforcement+of+%2410.9+million+judgment+in+Korea/26614138.html <p>RedHill Biopharma Ltd. (NASDAQ: RDHL) has commenced recognition and enforcement proceedings in Korea for a New York Supreme Court judgment totaling approximately $10.9 million against Kukbo Co. Ltd., according to a company statement.</p><p>The judgment became final in November 2025 after the New York Supreme Court ruled in favor of RedHill. An additional award for legal fees and expenses became final in March 2026 when Kukbo failed to perfect its appeal by the applicable deadline. No further appeals are permitted for either judgment.</p><p>The total award consists of approximately $8.9 million for the main judgment and approximately $1.95 million for legal fees http://www.streetinsider.com/Corporate+News/RedHill+initiates+enforcement+of+%2410.9+million+judgment+in+Korea/26614138.html Mon, 08 Jun 2026 07:01:11 -0400 CPIX RDHL http://www.streetinsider.com/Corporate+News/RedHill+initiates+enforcement+of+%2410.9+million+judgment+in+Korea/26614138.html <p>RedHill Biopharma Ltd. (NASDAQ: RDHL) has commenced recognition and enforcement proceedings in Korea for a New York Supreme Court judgment totaling approximately $10.9 million against Kukbo Co. Ltd., according to a company statement.</p><p>The judgment became final in November 2025 after the New York Supreme Court ruled in favor of RedHill. An additional award for legal fees and expenses became final in March 2026 when Kukbo failed to perfect its appeal by the applicable deadline. No further appeals are permitted for either judgment.</p><p>The total award consists of approximately $8.9 million for the main judgment and approximately $1.95 million for legal fees http://www.streetinsider.com/Corporate+News/RedHill+initiates+enforcement+of+%2410.9+million+judgment+in+Korea/26614138.html Mon, 08 Jun 2026 07:01:11 -0400 CPIX RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/Press+Releases/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nc.raleig" idsrc="xmltag.org" >RALEIGH</location>, N.C. and <location value="LU/il..telavv" idsrc="xmltag.org" >TEL-AVIV, Israel</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.redhillbio.com/home/default.aspx" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:RDHL" idsrc="xmltag.org" >RedHill Biopharma Ltd.</span></a> (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in <location value="LC/kr" idsrc="xmltag.org" >Korea</location> in respect of the <span>New York Supreme Court's</span> final judgment in favor of RedHill against <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo Co. Ltd</span> ("<span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span>"), totaling approximately <money>$10.9 million</money>, and that <span value="ACORN:2217748237" idsrc="xmltag.org" >Kukbo</span> has now been served in those proceedings.</p> <div id="prni_dvprnejpgccb9left" dir="ltr" style="width: 100%; text-align: http://www.streetinsider.com/PRNewswire/RedHill+Launches+Enforcement+of+%2411+Million+New+York+Supreme+Court+Final+Judgment+Against+Kukbo/26614095.html Mon, 08 Jun 2026 07:00:00 -0400 A.22177482 CPIX O.00044279 O.00674056 O.13804664 RDHL